NovImmune Company
NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.
Investors
Connections
Employee Number:
101-250
Headquarters:
Plan-les-ouates, Geneve, Switzerland, Europe
Founded Date:
1998-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 22 552 72 00
Investors:
Aravis Ventures, BZ Bank, Novartis Venture Fund, Pictet Private Equity Investors S.A., Reference Capital SA
Ipo Status:
private
City:
Plan-les-Ouates
Region:
Geneve
Country:
Switzerland
Founders:
Bernard Mach